(information subject to change)
Overview | Friday | Saturday | Sunday | Monday | Tuesday | Wednesday | Thursday
|
Tuesday, June 29, 2010 |
| |
|
6:30 AM–7:00 AM |
Sunrise Mini Course Coffee and Continental Breakfast—Marriott Ballroom VI |
| |
|
|
7:00 AM–5:00 PM |
Registration—Marriott Ballroom VI Foyer |
| |
|
|
7:00 AM–8:20 AM |
Sunrise Mini Course (Separate registration required)—Marriott Ballroom VI |
|
|
Imaging Tools for Structural and Functional Teratogenesis Analyses |
|
|
Organized by the Education Committee, Chairperson, Louise M. Winn, Queen’s University |
| |
|
|
7:00 AM–7:40 AM |
Imaging Tools for Structural Analysis |
| |
William Slikker, Jr., National Center for Toxicological Research, U.S. FDA |
| |
|
|
7:40 AM–8:20 AM |
Imaging Tools for Functional Analysis |
|
|
Julia M. Stephen, University of New Mexico |
| |
|
8:00 AM–2:00 PM |
Exhibit Hall Open—Marriott Ballroom I |
| |
|
|
8:30 AM–9:15 AM |
TS/NBTS/OTIS Joint Special Lecture—Marriott Ballroom VI |
| |
Children's Environmental Health: A Good Start Lasts a Lifetime |
| |
Linda S. Birnbaum, National Institute of Environmental Health Sciences |
| |
|
9:15 AM–9:30 AM |
Break—Marriott Ballroom I |
| |
|
9:30 AM–12:00 NOON |
March of Dimes/Public Affairs Committee Symposium—Marriott Ballroom VI |
|
Herbal Supplement Usage during Pregnancy |
| |
Chairpersons: Patricia M. Bittner, U.S. Consumer Product Safety
Commission, Chair, Public Affairs Committee and Richard K. Miller,
University of Rochester Medical Center |
|
Organized by the Public Affairs Committee
|
9:30 AM–10:00 AM |
Herbal Usage during Pregnancy: Teratology Society White Paper |
| |
Richard K. Miller, University of Rochester Medical Center |
|
|
| 10:00 AM–10:30 AM |
Herbal Preparations Usage and Pregnancy |
|
Henry M. Hess, University of Rochester Medical Center |
|
|
10:30 AM–11:00 AM |
Herbal Products: Are They What They Claim to Be? |
|
William R. Obermeyer, ConsumerLab.com |
|
|
| 11:00 AM–11:10 AM |
Herbal Drugs in Pregnancy: A Canadian Perspective |
|
Gideon Koren, The Hospital for Sick Children |
| |
|
| 11:10 AM–11:20 AM |
Traditional Chinese Medicine: Herbal Medicine Origins and Utilization in China |
| |
Robert L. Brent, Alfred I. duPont Hospital for Children |
| |
|
| 11:20 AM–11:30 AM |
Herbal Preparations: Are We at the Beginning of Regulations? The Situation in Europe and the Eastern Mediterranean Region |
| |
Asher Ornoy, Hebrew University Hadassah Medical School and Israeli Ministry of Health |
| |
|
| 11:30 AM–12:00 NOON |
Panel Discussion of Position Paper and Topic |
|
Patricia M. Bittner, U.S. Consumer Product Safety Commission, Chair, Public Affairs Committee |
| |
|
|
9:30 AM–12:00 NOON |
Joint TS/NBTS Symposium—Marriott Ballroom VII |
| |
Advancing Neurodevelopmental Evaluation in Children: An Interdisciplinary Approach |
|
|
Chairperson: Susan Makris, U.S. Environmental Protection Agency |
| |
|
| 9:30 AM–9:55 AM |
The Use of Neurodevelopmental Data in Children for Risk Assessment of Environmental Chemicals |
| |
Susan Makris, U.S. Environmental Protection Agency |
| |
|
| 9:55 AM–10:20 AM |
A Multidisciplinary Approach to Advancing the Science of Neurodevelopmental Testing in Cohorts of Infants and Young Children |
| |
Judy S. LaKind, LaKind Associates, LLC |
| |
|
| 10:20 AM–10:45 AM |
Getting the Biggest Bang for Your Buck: Choosing Neurodevelopmental Tests That Maximize Power |
| |
Lauren Kenworthy, George Washington University Medical School |
| |
|
| 10:45 AM–11:10 AM |
Threats to Study Validity: The Flynn Effect, Examiner Drift, Confounders, Lost in Translation, and Other Important Considerations |
| |
Laura Gutermuth Anthony, George Washington University School of Medicine |
| |
|
| 11:10 AM–11:35 AM |
Weight-of-the-Evidence Assessment in Neurodevelopmental Epidemiology: A Plea for Consistency |
| |
Michael Goodman, Emory University |
| |
|
| 11:35 AM–12:00 NOON |
Panel Discussion |
| |
|
|
12:00 NOON–2:00 PM |
TS/NBTS Joint Poster Session and Exhibits Open—Marriott Ballroom I |
| |
Tuesday Poster Session Listings |
| |
|
|
2:00 PM–4:30 PM |
Platform Session III—Marriott Ballroom VI |
| |
Hazard Assessment and Screening |
| |
|
| 2:00 PM–2:15 PM |
Effects of In Utero Exposure to Mono-2-ethylhexylphthalate (MEHP) on the Adult Female Mouse |
| |
Moyer BJ, Hixon ML. Brown University, Providence, RI, United States. |
| |
|
| 2:15 PM–2:30 PM |
Micro-CT and Alizarin Red Evaluations of Fetal Rat and Rabbit Skeletal Abnormalities Induced by All-Trans-Retinoic Acid |
| |
Wise LD1, Xue D2, Winkelmann CT2. 1Toxicological Sciences, Merck Research Laboratories, West Point, PA, United States, 2Imaging Department, Merck Research Laboratories, West Point, PA, United States. |
| |
|
| 2:30 PM–2:45 PM |
Effects of Bisphenol A and Diethylstilbestrol on the Adult Male Reproductive System Following Oral Administration to Pregnant C57BL6 Mice on Gestational Days 10 through 16 |
| |
Hixon ML, LaRocca J, Boyajian A, Brown C, Duncan Smith S. Brown University, Providence, RI, United States. |
| |
|
| 2:45 PM–3:00 PM |
Gonadal Responses to Vinclozolin Administered Orally to Han Wistar Rats |
| |
Tyl RW1, Seely JC2, Marr MC1, Myers CB1, Youn VY1, Browning DB1, Bishop JB3. 1RTI International, Research Triangle Park, NC, United States, 2Experimental Pathology Laboratories, Inc., Research Triangle Park, NC, United States, 3National Toxicology Program/NIEHS/NIH, Research Triangle Park, NC, United States. |
| |
|
| 3:00 PM–3:15 PM |
Break |
| |
|
| 3:15 PM–3:30 PM |
Maternal Diet Modulates the Rate of Neural Tube Defects in Diabetic Pregnancies |
| |
Kappen C, Kruger C, MacGowan J, Salbaum JM. Pennington Biomedical Research Center, Baton Rouge, LA, United States. |
| |
|
| 3:30 PM–3:45 PM |
Mammary Gland Development As a Sensitive Indicator of Early Life Exposures: Recommendations from an Interdisciplinary Workshop |
| |
Fenton SE1, Rudel RA2, Euling SY3, Makris SL3. 1National Institute of Environmental Health Sciences, National Toxicology Program, Research Triangle Park, NC, United States, 2Silent Spring Institute, Newton, MA, United States, 3NCEA, U.S. EPA, Washington, DC, United States. |
| |
|
| 3:45 PM–4:00 PM |
Assessment of Reproductive and Developmental Toxicity of Mixtures of Regulated Drinking Water Chlorination By-Products in a Multigenerational Rat Bioassay |
| |
Narotsky MG1, Klinefelter GR1, Goldman JM1, Strader LF1, Suarez JD1, Pressman JG2, Miltner RJ2, Speth T2, Teuschler LK3, Rice GE3, Richardson SD4, Best DS1, McDonald A1, Murr AS1, Hunter ES1, Simmons JE1. 1National Health and Environmental Effects Research Laboratory, ORD, U.S. EPA, Research Triangle Park, NC, United States, 2National Risk Management Research Laboratory, ORD, U.S. EPA, Cincinnati, OH, United States, 3National Center for Environmental Assessment, ORD, U.S. EPA, Cincinnati, OH, United States, 4National Exposure Research Laboratory, ORD, U.S. EPA, Athens, GA, United States. |
| |
|
| 4:00 PM–4:15 PM |
A Fishy Solution to Reproductive Toxicity Screening or Just a Red Herring? Zebrafish in Developmental Toxicity: Value within Pharmaceutical Development |
| |
Van den Bulck K1, Hill A2, Jones M2, Dodd A2, Mesens N1, Bailey GP1, De Schaepdrijver L1, Lammens L1. 1Johnson & Johnson Pharmaceutical Research & Development, Beerse, Belgium, 2Evotec AG, Hamburg, Germany. |
| |
|
| 4:15 PM–4:30 PM |
Establishment of a Statistical Prediction Model and Abbreviated Assay Design for Teratogenicity Screening of Compounds Using Rat Whole Embryo Culture |
| |
Zhang CXZ, Cao JC, Panzica-Kelly JPK, Stock DS, Augustine-Rauch KAA. Bristol Myers Squibb, Pennington, NJ, United States. |
| |
|
|
|
|
2:00 PM–4:15 PM |
TS/OTIS Joint Platform Session IV —Marriott Ballroom IX |
| |
Common Conditions in Pregnancy: Treatment of Mental Health and Asthma |
| |
|
| 2:00 PM–2:15 PM |
Patterns of Psychotropic Drug Use in Pregnancy and Lactation: The MotherSafe Experience 2000–2007 |
| |
Eamus M1, Oei J1,2, Hill M3, Taylor T3, Kennedy D1,3. 1School of Women’s and Children’s Health, University of NSW, Kensington, NSW, Australia, 2Dept. of Neonatology, Royal Hospital for Women, Randwick, NSW, Australia, 3MotherSafe, Royal Hospital for Women, Randwick, NSW, Australia. |
| |
|
| 2:15 PM–2:30 PM |
Birth Defects, Preterm Bi
rth and Intrauterine Growth in the Offspring of Women Prescribed Citalopram during Pregnancy |
| |
Colvin L1,2, Slack-Smith L2, Stanley FJ1, Bower C1. 1Centre for Child Health Research, Telethon Institute for Child Health Research, The University of Western Australia, West Perth, Australia, 2School of Dentistry, The University of Western Australia, West Perth, Australia. |
| |
|
| 2:30 PM–2:45 PM |
The Safety of Escitalopram in Pregnancy: A Prospective Cohort Study |
| |
Klieger-Grossmann C1, Weitzner B1, Einarson T2, Koren G1, Einarson ?A1. 1The Motherisk Program, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 2Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada. |
| |
|
| 2:45 PM–3:00 PM |
Neurodevelopment of Children Exposed In Utero to Venlafaxine: Preliminary Results |
| |
Nulman I1,2, Barrera M1,2, Pulver A1, Streiner D2,3, Feldman B1,2, Koren G1,2. 1The Hospital for Sick Children, Toronto, ON, Canada, 2The University of Toronto, Toronto, ON, Canada, 3Baycrest Centre, Toronto, ON, Canada. |
| |
|
| 3:00 PM–3:15 PM |
Break |
| |
|
| 3:15 PM–3:30 PM |
Impact of Changing the Dose of Inhaled Corticosteroids during Pregnancy on the Risk of Maternal Asthma Exacerbations |
| |
Blais L1,2, Kettani F2, Ducharme FM3, Lemière C1,2, Beauchesne M-F1, Bérard A1. 1Université de Montréal, Montréal, QC, Canada, 2Hôpital du Sacré-Coeur de Montréal, Montréal, QC, Canada, 3CHU Ste-Justine, Montréal, QC, Canada. |
| |
|
| 3:30 PM–3:45 PM |
Congenital Anomalies in Asthmatic Women Using Corticosteroids during Pregnancy: A Meta Analysis from Published Data |
| |
Namazy JA1, Murphy VE2,3, Powell H2,4, Gibson PG2,4, Chambers CD5, Schatz M6. 1Scripps Clinic, San Diego, CA, United States, 2University of Newcastle, Newcastle, NSW, Australia, 3Hunter Medical Research Institute, Newcastle, NSW, Australia, 4John Hunter Hospital, Newcastle, NSW, Australia, 5University of California San Diego, La Jolla, CA, United States, 6Kaiser Permanente Medical Center, San Diego, CA, United States. |
| |
|
| 3:45 PM–4:00 PM |
Risk of Perinatal Mortality Associated with the Use of Inhaled Corticosteroids for the Treatment of Asthma during Pregnancy |
| |
Breton MCB1, Beauchesne MFB1,2, Lemière CL2, Rey ER3, Amélie AF2, Blais LB1,2. 1Universite de Montreal, Montreal, QC, Canada, 2Research Center, Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada, 3Obstetric and Gynecology Department, CHU Ste-Justine, Montreal, QC, Canada. |
| |
|
| 4:00 PM–4:15 PM |
Perception of Teratogenicity among Pregnant Women with Asthma or Diabetes Mellitus |
| |
Sarangarm P1, Liu S1, Young BN1, Phelan ST2, Nawarskas J1, Rayburn WF2, Bakhireva LN1. 1University of New Mexico, College of Pharmacy, Albuquerque, NM, United States, 2University of New Mexico, Department of Obstetrics and Gynecology, Albuquerque, NM, United States. |
| |
|
| 4:45 PM–6:30 PM |
50th Anniversary Meeting Celebration—Marriott Ballroom VI |
| |
Organized by the 50th Anniversary Planning Committee |
| |
|
| 4:45 PM–4:50 PM |
Introduction |
| |
John M. Rogers, U.S. Environmental Protection Agency |
| |
|
| 4:50 PM–5:10 PM |
Josef Warkany: Then and Now |
| |
Wladimir Wertelecki, University of South Alabama |
| |
|
| 5:10 PM–5:30 PM |
James G. Wilson, Embryologist, Teratologist, Founding Member of the Teratology Society, Superb Researcher, Teacher and Human Being |
| |
Robert L. Brent, Alfred I. duPont Hospital for Children |
| |
|
| 5:30 PM–5:45 PM |
Distinguished Service Award |
| |
Presented by Barbara Hales and Terence Ozolins |
| |
|
| 5:45 PM–6:00 PM |
Students' Viewpoints on the Future of the Teratology Society |
| |
|
| 6:00 PM–6:30 PM |
Let’s Play Jeopardy! History of the Teratology Society |
|
|
|
|